Bristol Myers Squibb (CELG-RI) Treasury Shares (2009 - 2026)

Bristol Myers Squibb has disclosed Treasury Shares across 18 years of filings, most recently posting $43.5 billion for Q1 2026.

• In Q1 2026, Treasury Shares changed 0.19% year-over-year to $43.5 billion; the TTM figure through Mar 2026 stood at $43.5 billion (changed 0.19% YoY), while the FY2025 annual figure was $43.6 billion, changed 0.17% from the prior year.
• Treasury Shares was little changed at $43.5 billion in Q1 2026, from $43.6 billion in the prior quarter.
• Over the last five years, Treasury Shares for CELG-RI reached as high as $896.0 million in Q1 2024 and fell as low as $12.0 million in Q3 2022.
• The 5-year median for Treasury Shares is $881.0 million (2026), against an average of $719.5 million.
• Annual changes were most pronounced in 2022 — Treasury Shares increased 29.37% — and 2024, when it retreated 0.25%.
• A 5-year view of Treasury Shares shows it stood at $38.6 billion in 2022, then gained by 13.33% to $43.8 billion in 2023, then fell by 0.25% to $43.7 billion in 2024, then declined by 0.17% to $43.6 billion in 2025, then retreated by 0.15% to $43.5 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $43.5 billion, $43.6 billion, and $43.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.